INVASIVE MAMMARY CARCINOMA
Clinical trials for INVASIVE MAMMARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE MAMMARY CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE MAMMARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene clues could improve chemo for advanced breast cancer
Disease control Recruiting nowThis study tests whether a gene test can help doctors pick the best second-line chemotherapy for people with a common type of advanced breast cancer (HR+ metastatic). About 64 participants will receive the drug capecitabine, and researchers will track how long their cancer stays …
Matched conditions: INVASIVE MAMMARY CARCINOMA
Phase: PHASE2 • Sponsor: Sonya Reid • Aim: Disease control
Last updated May 26, 2026 09:19 UTC
-
Cancer immunotherapy may weaken bones, new study warns
Knowledge-focused Recruiting nowThis study looks at how certain immunotherapy drugs (called immune checkpoint inhibitors) affect bone strength in people being treated for cancer. Researchers will measure bone density and blood markers in 25 patients over a year to see if these treatments increase fracture risk.…
Matched conditions: INVASIVE MAMMARY CARCINOMA
Phase: NA • Sponsor: Jessica Mezzanotte Sharpe • Aim: Knowledge-focused
Last updated May 26, 2026 08:57 UTC